ExploreWatchlistsPricing
  1. US-listed companies
  2. PACIFIC BIOSCIENCES OF CALIFORNIA, INC.
  3. Financials
  4. Cash and cash equivalents

PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB)

Market cap
$425.82M
P/E ratio
SummaryFinancials
Period EndCash and cash equivalents (Million USD)YoY (%)
Dec 31, 202565+13.31%
Dec 31, 202458-68.47%
Dec 31, 2023183-44.37%
Dec 31, 2022328-29.52%
Dec 31, 2021466+441.98%
Dec 31, 202086+155.59%
Dec 31, 201934+44.05%
Dec 31, 201823+41.42%
Dec 31, 201717-1.54%
Dec 31, 201617-50.15%
Dec 31, 201534-7.74%
Dec 31, 201436+38.26%
Dec 31, 201326-43.36%
Dec 31, 201247-20.94%
Dec 31, 201159

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating expenses Operating income Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSDividend payout ratio (%)Dividend per shareEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)
AI Chat